Visiomed Group

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last year, Visiomed Group had revenue of €13.71m and net profit of €902k

(EUR)	2023	YoY
Revenue	13.71m	5.12%
Gross profit	6.3m	96.75%
Net profit	902k	117.09%
EBITDA	6.81m	292.48%

Fundamentals

Metric	Value
Market capitalization	€52.99m
Number of shares	307.01m
52-week high/low	€0.53 - €0.16
Dividends	No
Beta	-0.62
P/E ratio	25.80
PEG ratio	0.26
P/B ratio	2.01
P/S ratio	2.49

Company profile

Visiomed Group SA develops and distributes electronic medical devices in Europe and internationally. It provides thermometers, blood pressure monitors, pulse oximeters, connected blood glucometers, and connected electrocardiograms; and pain relief products, such as electrotherapy. The company also offers connected scales and scalable baby scales, as well as prevention and treatment products, such as humidifiers and phototherapies. In addition, it provides hearing products and optics, including presbycusis, as well as family hygiene products. The company offers its products under the ThermoFlash, T. LeClerc, Visiocheck, Innoxa, and BewellConnect brands. Visiomed Group SA was founded in 2007 and is headquartered in Paris, France.